← FDA DRUG APPROVALS

FDA ANDA · ANDA074102

PIROXICAM

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA074102
TYPE
ANDA
ORIGINAL APPROVAL
1992-07-31
LATEST ACTION
2016-02-18
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PIROXICAMDiscontinued
PIROXICAM 10MG · CAPSULE · ORAL
PIROXICAMDiscontinued
PIROXICAM 20MG · CAPSULE · ORAL

Approval history

2016-02-18Labeling · Supplement 13 · standardAP
2008-05-08Labeling · Supplement 11AP
2006-07-03Labeling · Supplement 10AP
2004-01-02Labeling · Supplement 7AP
1998-02-05Manufacturing (CMC) · Supplement 4AP
1998-01-21Manufacturing (CMC) · Supplement 3AP
1994-03-09Manufacturing (CMC) · Supplement 1AP
1992-07-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →